Krystexxa

Free

Pegloticase (trade name Krystexxa) is a medication for the treatment of severe, treatment-refractory, chronic gout. It is a third line treatment in those in whom other treatments are not effective or are not tolerated

Submit an Enquiry
Category: Brand:

Description

In individuals with glucose-6-phosphate dehydrogenase deficiency, pegloticase may precipitate a severe, life-threatening hemolysis with methemoglobinemia; it is therefore contraindicated in such individuals. Pegloticase may also show immunogenicity, which can be diminished by co-administration with methotrexate.

Reviews

There are no reviews yet.

Be the first to review “Krystexxa”

Your email address will not be published. Required fields are marked *

Related products